Insider Buying: Percheron Therapeutics Ltd (ASX:PER) Insider Acquires A$10,500.00 in Stock

Percheron Therapeutics Ltd (ASX:PERGet Free Report) insider James Garner bought 1,500,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 24th. The shares were bought at an average price of A$0.01 ($0.00) per share, for a total transaction of A$10,500.00 ($6,521.74).

James Garner also recently made the following trade(s):

  • On Wednesday, November 27th, James Garner purchased 125,000 shares of Percheron Therapeutics stock. The shares were bought at an average cost of A$0.07 ($0.04) per share, for a total transaction of A$8,875.00 ($5,512.42).
  • On Thursday, November 14th, James Garner acquired 375,000 shares of Percheron Therapeutics stock. The stock was bought at an average cost of A$0.08 ($0.05) per share, with a total value of A$30,000.00 ($18,633.54).

Percheron Therapeutics Price Performance

Percheron Therapeutics Company Profile

(Get Free Report)

Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.

Recommended Stories

Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.